Forman Mark S has filed 18 insider transactions across 2 companies since August 2021.
Most recent transaction: a disposition of 350000 shares of Ventyx Biosciences, Inc. ($VTYX) on March 04, 2026.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 4, 2026 | Ventyx Biosciences, Inc. | $VTYX | Forman Mark S | Chief Medical Officer | D | Stock Option (Right to Buy) | 350000 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.49% |
| March 4, 2026 | Ventyx Biosciences, Inc. | $VTYX | Forman Mark S | Chief Medical Officer | D | Stock Option (Right to Buy) | 85000 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.12% |
| March 4, 2026 | Ventyx Biosciences, Inc. | $VTYX | Forman Mark S | Chief Medical Officer | D | Common Stock | 6000 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.01% |
| Nov. 17, 2025 | Ventyx Biosciences, Inc. | $VTYX | Forman Mark S | Chief Medical Officer | A | Common Stock | 3000 | $1.03 | 6,000.0000 | 71,358,638 | 100.00% | 0.00% |
| May 15, 2025 | Ventyx Biosciences, Inc. | $VTYX | Forman Mark S | Chief Medical Officer | A | Common Stock | 3000 | $1.03 | 3,000.0000 | 71,130,054 | 9999.99% | 0.00% |
| Jan. 2, 2025 | Ventyx Biosciences, Inc. | $VTYX | Forman Mark S | Chief Medical Officer | A | Stock Option (Right to Buy) | 85000 | $0.00 | 85,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 12, 2024 | Ventyx Biosciences, Inc. | $VTYX | Forman Mark S | Chief Medical Officer | A | Stock Option (Right to Buy) | 350000 | $0.00 | 350,000.0000 | 0 | 9999.99% | 0.00% |
| March 15, 2024 | Passage BIO, Inc. | $PASG | Forman Mark S | CHIEF MEDICAL OFFICER | A | Employee Stock Option (right to buy) | 203000 | $0.00 | 203,000.0000 | 54,743,490 | 9999.99% | 0.37% |
| Feb. 10, 2022 | Passage BIO, Inc. | $PASG | Forman Mark S | CHIEF MEDICAL OFFICER | A | Restricted Stock Unit | 15000 | $0.00 | 15,000.0000 | 53,343,959 | 9999.99% | 0.03% |
| Feb. 10, 2024 | Passage BIO, Inc. | $PASG | Forman Mark S | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 5000 | $0.00 | 10,000.0000 | 54,743,490 | 33.33% | 0.01% |
| Feb. 10, 2024 | Passage BIO, Inc. | $PASG | Forman Mark S | CHIEF MEDICAL OFFICER | M | Common Stock | 5000 | $0.00 | 50,269.0000 | 54,743,490 | 11.05% | 0.01% |
| Feb. 13, 2024 | Passage BIO, Inc. | $PASG | Forman Mark S | CHIEF MEDICAL OFFICER | S | Common Stock | 1638 | $0.97 | 48,631.0000 | 54,743,490 | 3.26% | 0.00% |
| Aug. 16, 2021 | Passage BIO, Inc. | $PASG | Forman Mark S | CHIEF MEDICAL OFFICER | A | Employee Stock Option (right to buy) | 130000 | $0.00 | 130,000.0000 | 53,885,651 | 9999.99% | 0.24% |
| Feb. 10, 2022 | Passage BIO, Inc. | $PASG | Forman Mark S | CHIEF MEDICAL OFFICER | A | Employee Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 53,343,959 | 9999.99% | 0.05% |
| Dec. 31, 2023 | Passage BIO, Inc. | $PASG | Forman Mark S | Chief Medical Officer | M | Restricted Stock Unit | 50000 | $0.00 | 0.0000 | 54,789,410 | 100.00% | 0.09% |
| Jan. 2, 2024 | Passage BIO, Inc. | $PASG | Forman Mark S | Chief Medical Officer | S | Common Stock | 15813 | $0.91 | 45,269.0000 | 54,743,490 | 25.89% | 0.03% |
| Dec. 31, 2023 | Passage BIO, Inc. | $PASG | Forman Mark S | Chief Medical Officer | M | Common Stock | 50000 | $0.00 | 61,082.0000 | 54,789,410 | 451.18% | 0.09% |
| March 15, 2023 | Passage BIO, Inc. | $PASG | Forman Mark S | Chief Medical Officer | A | Employee Stock Option (right to buy) | 175000 | $0.00 | 175,000.0000 | 54,429,023 | 9999.99% | 0.32% |